Medical Devices - CardiAI™

CardiAI™ is a leading-edge developer of Point of care medical diagnostic technologies. We are developing platform technologies that will transform healthcare worldwide. CardiAI™ prioritizes patient-centric care by communicating and emphasizing patient needs to their health care and information providers. CardiAI™ has a very tenacious R&D team with the capabilities ranging from biomedical engineers, electrochemical engineers, molecular biologists, business development professionals, project managers, clinical managers and clinical trial specialists.The company has developed an electrochemical biosensing based technology platform which it is using to develop Point of Care rapid diagnostic tests for Covid-19, Heart failure, and metabolic disorders (such as diabetes) etc. Using AI and machine learning approaches to monitor patient parameters, CardiAI™ anticipates to improve quality of life and reduce healthcare cost.

CoviLamp™

CoviLamp™ is Rapid Detection Kit (Real-Time Loop Mediated Isothermal Amplification test) intended for the qualitative detection of SARS-CoV-2 in upper and lower respiratory specimens. Results are delivered in as low as 30-40 minutes.

CoviLamp™

CoviLamp™ is Rapid Detection Kit (Real-Time Loop Mediated Isothermal Amplification test) intended for the qualitative detection of SARS-CoV-2 in upper and lower respiratory specimens. Results are delivered in as low as 30-40 minutes.

CoviAro™

CoviAro™ test kit

CoviAro™ reader along with the CardiAI-Covi test strip can provide users with COVID-19 test results under 30 min. CardiAI’s COVID-19 companion mobile application CoviAro in conjunction with PhilAro provides users with peace of mind and a vital tool to communicate with health care providers about management and triaging protocol if infected or to prevent covid19 infection. CoviAro uses the CovSense System for quantitative/qualitative electrochemical measurement of COVID19 RNA using hybridization assay from nasopharyngeal samples prepared through a microfluidic sample preparation device that utilizes nasal swabs. The CovSense is intended for in vitro diagnostic, used by patients at home as a screening tool to monitor the spread of the COVID-19 infection.

PhilAro

Phil Aro reader along with the CardiAI-Covi test strip can provide users with COVID-19 test results under 30 min. CardiAI’s COVID-19 companion mobile application CoviAro in conjunction with Phil Aro provides users with peace of mind and a vital tool to communicate with health care providers about management and triaging protocol if infected or to prevent covid19 infection.

PhilAro

Phil Aro reader along with the CardiAI-Covi test strip can provide users with COVID-19 test results under 30 min. CardiAI’s COVID-19 companion mobile application CoviAro in conjunction with Phil Aro provides users with peace of mind and a vital tool to communicate with health care providers about management and triaging protocol if infected or to prevent covid19 infection.

Test Strips

CardiAI diagnostic biomarker /biomolecule strips are screen printed electrodes made from CardiAI’s propriety conductive ink. CardiAI’s diagnostic strip is designed to normalize sample variation seen between individuals to deliver precise quantification of target biomarker/biomolecule. CardiAI uses unique electrochemical techniques to quantify biomarkers / biomolecules comparable to gold standard sensitivity and selectivity.

NT-ProBNP Strips
NT-ProBNP strips are antibody-based diagnostic strips diligently designed to measure circulating NT-ProBNP biomarkers from a finger stick.

Glucose Strips
Glucose strips are the world's first enzyme less, direct blood glucose diagnostic test strips which can measure blood glucose from a finger stick.

CoviFlo
CoviFlo test strips are CardiAI’s new nucleic acid-based diagnostic test strips designed to perform fast and accurate Covid19 testing. CoviFlo can integrate with CardiAI Covid-19 devices to work with various samples, including swab and saliva.

Philos

PHILOS is a medical device designed for the patients and HCPs integrated with Artificial Intelligence.

Philos reader is the world’s first multiport reader capable to read multiple test strip simultaneously to provide users with comprehensive data about their health.

Philos reader is designed for patients to monitor and manage their chronic conditions, including diabetics and cardiovascular ailments.

Philos is a handheld reader that reads the biomarker information from the CardiAI’s electrochemical test strip. Philos has a touch screen interface that allows users to set up their user profile before running a test at the comfort of their homes. The electronics within the device is designed to accept CardiAI Inc’s proprietary strips. On reading the data, the device securely transmits the results to a companion mobile application via Bluetooth, allowing the user to share their health data with their trusted health care professionals.

Philos

PHILOS is a medical device designed for the patients and HCPs integrated with Artificial Intelligence.

Philos reader is the world’s first multiport reader capable to read multiple test strip simultaneously to provide users with comprehensive data about their health.

Philos reader is designed for patients to monitor and manage their chronic conditions, including diabetics and cardiovascular ailments.

Philos is a handheld reader that reads the biomarker information from the CardiAI’s electrochemical test strip. Philos has a touch screen interface that allows users to set up their user profile before running a test at the comfort of their homes. The electronics within the device is designed to accept CardiAI Inc’s proprietary strips. On reading the data, the device securely transmits the results to a companion mobile application via Bluetooth, allowing the user to share their health data with their trusted health care professionals.